Tubidy
    The average time from FDA approval to M&A (oncology biopharma) since 1/1/2017. #biotechstocks

    The average time from FDA approval to M&A (oncology biopharma) since 1/1/2017. #biotechstocks

    01:00 |
    Download MP3

    Related Videos

    Commercial Stage Oncology Focused Bio Q3 2024 Share Prices Through 9282024 14:47

    Commercial Stage Oncology Focused Bio Q3 2024 Share Prices Through 9282024

    Revenue Multiples Paid AbbVie to Buy ImmunoGen 2:49

    Revenue Multiples Paid AbbVie to Buy ImmunoGen

    Q2 2024 Commercial Stage BioPharma Revenues v Estimates Thru August 9, 2024. More to come soon. 1:00

    Q2 2024 Commercial Stage BioPharma Revenues v Estimates Thru August 9, 2024. More to come soon.

    The average time from FDA approval to M&A (oncology biopharma) since 1/1/2017. #biotechstocks 1:00

    The average time from FDA approval to M&A (oncology biopharma) since 1/1/2017. #biotechstocks

    Jazz Pharma Hypothetical M&A Value Using Cumulative 10-Year Revenue Multiples Paid to Buy Bioverativ 7:14

    Jazz Pharma Hypothetical M&A Value Using Cumulative 10-Year Revenue Multiples Paid to Buy Bioverativ

    Intra-Cellular Therapies (ticker ITCI) hypothetical valuations (EV/MC) in a near-term acquisition. 1:00

    Intra-Cellular Therapies (ticker ITCI) hypothetical valuations (EV/MC) in a near-term acquisition.

    Analyst v Management Revenue Estimates in the 3 Most Recent Oncology Focused M&A #biotechstocks 1:00

    Analyst v Management Revenue Estimates in the 3 Most Recent Oncology Focused M&A #biotechstocks

    16 Commercial-Stage Oncology Focused Biopharmas M&A Potential. #biotechstocks #mergers 8:07

    16 Commercial-Stage Oncology Focused Biopharmas M&A Potential. #biotechstocks #mergers

    Beautiful Relaxing Music - Relaxing Music for Meditation, Spa, Stress Relief, Healing Therapy Soul 11:41:30

    Beautiful Relaxing Music - Relaxing Music for Meditation, Spa, Stress Relief, Healing Therapy Soul

    Enanta Pharmaceuticals Market Cap v Liquidation Value 4:22

    Enanta Pharmaceuticals Market Cap v Liquidation Value

    Will 1 of the 15 comm'l-stage oncology focused biopharmas be acquired at the Jan 24 JPM HC Conf? 1:00

    Will 1 of the 15 comm'l-stage oncology focused biopharmas be acquired at the Jan 24 JPM HC Conf?

    Actual Q224 Sales v. Consensus; 6 Comm'l-Stage Oncology Focused Biopharmas (Market Cap of 1 - $5B). 10:02

    Actual Q224 Sales v. Consensus; 6 Comm'l-Stage Oncology Focused Biopharmas (Market Cap of 1 - $5B).

    Does Springworks (SWTX) Option Trading Suggest a Buyout is Imminent? What's a Hypothetical Price? 11:23

    Does Springworks (SWTX) Option Trading Suggest a Buyout is Imminent? What's a Hypothetical Price?

    Share Price Activity of Small(er) Cap BioPharma Before v. After Their First FDA Approval. 5:39

    Share Price Activity of Small(er) Cap BioPharma Before v. After Their First FDA Approval.

    Q2 2024 Sales v Consensus To Date Commercial Stage BioPharmas 10:09

    Q2 2024 Sales v Consensus To Date Commercial Stage BioPharmas

    Revenue Multiples Paid by Bristol Myers (BMY) in the Mirati Therapeutics (MRTX) Acquisition 5:29

    Revenue Multiples Paid by Bristol Myers (BMY) in the Mirati Therapeutics (MRTX) Acquisition

    Revenue Multiples Per Management Forecasts in 3 Recent Commercial Stage Oncology M&A Transactions 20:19

    Revenue Multiples Per Management Forecasts in 3 Recent Commercial Stage Oncology M&A Transactions

    Combining Reactions and Equilibrium Constants Given: N2(g) + 1/2Br2(g) ⇌ NOBr(g) K = 1.40 2NO(g) … 0:33

    Combining Reactions and Equilibrium Constants Given: N2(g) + 1/2Br2(g) ⇌ NOBr(g) K = 1.40 2NO(g) …

    Aadi Biosciences Risk v Reward Profile at $1.76 a share. #biotechstocks 17:00

    Aadi Biosciences Risk v Reward Profile at $1.76 a share. #biotechstocks

    Iovance Hypothetical FY2026 M&A Valuation Using Most Recent Peer Transaction Multiples (incl. IMGN) 15:17

    Iovance Hypothetical FY2026 M&A Valuation Using Most Recent Peer Transaction Multiples (incl. IMGN)